In this context, both APE1 and STAT3 proteins have been listed as possible targets (Banerjee and Resat 2016; Wen et al. 2016), and the combined inhibition of these proteins led to a decrease in cancer cell survival in pancreatic and bladder cancer (Caston et al. 2021). Here, STAT3 is linked to cancer.